Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

15.50p
   
  • Change Today:
    -0.50p
  • 52 Week High: 21.00
  • 52 Week Low: 7.38
  • Currency: UK Pounds
  • Shares Issued: 637.29m
  • Volume: 30,952
  • Market Cap: £98.78m
  • RiskGrade: 312

Latest ShareCast News

Allergy Therapeutics screens first patients in grass pollen study

By Josh White

Date: Monday 26 Oct 2020

(Sharecast News) - Commercial biotechnology company Allergy Therapeutics announced the screening of the first patient in its exploratory field study 'G309', to evaluate the efficacy and safety of 'Grass MATA MPL' in subjects with seasonal allergic rhinitis or rhinoconjunctivitis induced by grass pollen exposure.

AGY News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AGY Market Data

Currency UK Pounds
Share Price 15.50p
Change Today -0.50p
% Change -3.13 %
52 Week High 21.00
52 Week Low 7.38
Volume 30,952
Shares Issued 637.29m
Market Cap £98.78m
RiskGrade 312

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.59% below the market average44.59% below the market average44.59% below the market average44.59% below the market average44.59% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Price Trend
76.30% above the market average76.30% above the market average76.30% above the market average76.30% above the market average76.30% above the market average
48.28% above the sector average48.28% above the sector average48.28% above the sector average48.28% above the sector average48.28% above the sector average
Income Not Available
Growth
84.40% above the market average84.40% above the market average84.40% above the market average84.40% above the market average84.40% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AGY Dividends

No dividends found

Trades for 30-Nov-2020

Time Volume / Share Price
15:42 2,879 @ 15.05p
14:42 312 @ 15.98p
12:32 12,500 @ 15.58p
12:06 117 @ 15.02p
09:40 1,161 @ 15.10p

AGY Key Personnel

CEO Manuel Llobet
Finance Director Nicolas Wykeman

Top of Page